Mitochondrial dysfunction in autism
Open accessAbstract
CONTEXT: Impaired mitochondrial function may influence processes highly dependent on energy, such as neurodevelopment, and contribute to autism. No studies have evaluated mitochondrial dysfunction and mitochondrial DNA (mtDNA) abnormalities in a well-defined population of children with autism. OBJECTIVE: To evaluate mitochondrial defects in children with autism. DESIGN, SETTING, AND PATIENTS: Observational study using data collected from patients aged 2 to 5 years who were a subset of children participating in the Childhood Autism Risk From Genes and Environment study in California, which is a population-based, case-control investigation with confirmed autism cases and age-matched, genetically unrelated, typically developing controls, that was launched in 2003 and is still ongoing. Mitochondrial dysfunction and mtDNA abnormalities were evaluated in lymphocytes from 10 children with autism and 10 controls. MAIN OUTCOME MEASURES: Oxidative phosphorylation capacity, mtDNA copy number and deletions, mitochondrial rate of hydrogen peroxide production, and plasma lactate and pyruvate. RESULTS: The reduced nicotinamide adenine dinucleotide (NADH) oxidase activity (normalized to citrate synthase activity) in lymphocytic mitochondria from children with autism was significantly lower compared with controls (mean, 4.4 [95% confidence interval {CI}, 2.8-6.0] vs 12 [95% CI, 8-16], respectively; P = .001). The majority of children with autism (6 of 10) had complex I activity below control range values. Higher plasma pyruvate levels were found in children with autism compared with controls (0.23 mM [95% CI, 0.15-0.31 mM] vs 0.08 mM [95% CI, 0.04-0.12 mM], respectively; P = .02). Eight of 10 cases had higher pyruvate levels but only 2 cases had higher lactate levels compared with controls. These results were consistent with the lower pyruvate dehydrogenase activity observed in children with autism compared with controls (1.0 [95% CI, 0.6-1.4] nmol × [min × mg protein](-1) vs 2.3 [95% CI, 1.7-2.9] nmol × [min × mg protein](-1), respectively; P = .01). Children with autism had higher mitochondrial rates of hydrogen peroxide production compared with controls (0.34 [95% CI, 0.26-0.42] nmol × [min × mg of protein](-1) vs 0.16 [95% CI, 0.12-0.20] nmol × [min × mg protein](-1) by complex III; P = .02). Mitochondrial DNA overreplication was found in 5 cases (mean ratio of mtDNA to nuclear DNA: 239 [95% CI, 217-239] vs 179 [95% CI, 165-193] in controls; P = 10(-4)). Deletions at the segment of cytochrome b were observed in 2 cases (ratio of cytochrome b to ND1: 0.80 [95% CI, 0.68-0.92] vs 0.99 [95% CI, 0.93-1.05] for controls; P = .01). CONCLUSION: In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 24 cited sources checked · 0 supported · 0 flagged
- Findingown data
In lymphocytic mitochondria from children with autism, NADH oxidase activity normalized to citrate synthase was significantly lower than in controls, with a mean of 4.4 versus 12 (P=.001).
“The reduced nicotinamide adenine dinucleotide (NADH) oxidase activity (normalized to citrate synthase activity) in lymphocytic mitochondria from children with autism was significantly lower compared with controls (mean, 4.4 [95% confidence interval {CI}, 2.8-6.0] vs 12 [95% CI, 8-16], respectively; P=.001).”
- Also stated in: § RESULTS · plain
“The NADH oxidase activities (normalized to citrate synthase) in samples from children with autism and controls were 4.4 (95% CI, 2.8-6.0) and 12 (95% CI, 8-16), respectively (P=.001; TABLE 2).”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Mitochondrial hydrogen peroxide production at complex I was higher in children with autism than in controls, with means of 0.15 versus 0.07 nmol×[min×mg protein]−1 (P=.03).
“The rates of hydrogen peroxide production in lymphocytic mitochondria from children with autism were higher compared with controls at both complex I (0.15 [95% CI, 0.05-0.25] nmol of hydrogen peroxide × [min × mg of protein]−1 vs 0.07 [95% CI, 0.03-0.11] nmol of hydrogen peroxide × [min × mg of protein]−1, respectively; P=.03) and complex III (0.34 [95% CI, 0.26-0.42] nmol of hydrogen peroxide × [”
Quote in the paperSubstantial claim - Findingown data
Mitochondrial hydrogen peroxide production at complex III was higher in children with autism than in controls, with means of 0.34 versus 0.16 nmol×[min×mg protein]−1 (P=.02).
“Children with autism had higher mitochondrial rates of hydrogen peroxide production compared with controls (0.34 [95% CI, 0.26-0.42] nmol×[min×mg of protein]−1 vs 0.16 [95% CI, 0.12-0.20] nmol×[min×mg protein]−1 by complex III; P=.02).”
- Also stated in: § RESULTS · plain
“The rates of hydrogen peroxide production in lymphocytic mitochondria from children with autism were higher compared with controls at both complex I (0.15 [95% CI, 0.05-0.25] nmol of hydrogen peroxide × [min × mg of protein]−1 vs 0.07 [95% CI, 0.03-0.11] nmol of hydrogen peroxide × [min × mg of protein]−1, respectively; P=.03) and complex III (0.34 [95% CI, 0.26-0.42] nmol of hydrogen peroxide × [”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Most children with autism (6 of 10) had complex I activity below the control range.
“The majority of children with autism (6 of 10) had complex I activity below control range values.”
- Also stated in: § RESULTS · plain
“the most common deficiency was found at the level of complex I (6 of 10), mainly in combination with complex V (4 of 10), followed by complex IV or complex III only (1 of 10 each).”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Plasma pyruvate levels were significantly higher in children with autism than in controls, with means of 0.23 mM versus 0.08 mM (P=.02).
“Higher plasma pyruvate levels were found in children with autism compared with controls (0.23 mM [95% CI, 0.15-0.31 mM] vs 0.08 mM [95% CI, 0.04-0.12 mM], respectively; P=.02).”
- Also stated in: § RESULTS · plain
“mean plasma pyruvate level was significantly higher in children with autism (0.23 mM; 95% CI, 0.15-0.31 mM) compared with controls (0.08 mM; 95% CI, 0.04-0.12 mM) (P=.02)”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Pyruvate dehydrogenase complex activity was lower in children with autism than in controls, with means of 1.0 versus 2.3 nmol×[min×mg protein]−1 (P=.01).
“These results were consistent with the lower pyruvate dehydrogenase activity observed in children with autism compared with controls (1.0 [95% CI, 0.6-1.4] nmol×[min×mg protein]−1 vs 2.3 [95% CI, 1.7-2.9] nmol×[min×mg protein]−1, respectively; P=.01).”
- Also stated in: § RESULTS · plain
“In children with autism, the mean PDHC activity was 1.0 (95% CI, 0.6-1.4) nmol×[min×mg of protein]−1 compared with 2.3 (95% CI, 1.7-2.9) nmol × [min × mg of protein]−1 in control children (P=.01; Table 2).”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingreasoning
The lactate-to-pyruvate ratio was significantly lower in children with autism than in controls, with means of 6 versus 12 (P=.002).
“and as a consequence, the lactate-to-pyruvate ratio was also significantly lower (6 [95% CI, 4-8] and 12 [95% CI, 8-16], respectively; P=.002).”
Quote in the paperSubstantial claim - Findingown data
All children with autism who had mtDNA deletions also had mtDNA overreplication.
“All children with autism that had mtDNA deletions also had mtDNA overreplication.”
Quote in the paperNot a substantial claim - Findingown data
Only 1 of 10 children with autism fulfilled diagnostic criteria for a definite mitochondrial respiratory chain disorder (10%).
“Only 1 child with autism in this study fulfilled the diagnostic criteria for a definite mitochondrial respiratory chain disorder16 (10% or 1 of 10 children).”
Quote in the paperSubstantial claim - Findingown data
In controls, the lymphocyte mtDNA-to-nuclear-DNA ratio was 497% of the mean granulocyte value.
“In the controls, the ratio of mtDNA to nuclear DNA in lymphocytes was 179 (95% CI, 165-193), which was 497% of mean granulocyte values (36 [95% CI, 1-73]; Table 3)”
Quote in the paperNot a substantial claim - Findingown data
No deletions at the ND4 segment were found in children with autism.
“whereas there were no deletions at the segment encoded by ND4 (Table 3).”
Quote in the paperNot a substantial claim - Findingown data
Mean mtDNA copy number in granulocytes was higher in children with autism than in controls, with means of 54 versus 36 (P=.02).
“A higher mean mtDNA copy number was obtained in granulocytes from children with autism vs controls (54 [95% CI, 24-87] vs 36 [95% CI, 1-73]; P=.02), indicating that the mtDNA overreplication was not cell-dependent (eTable 3).”
Quote in the paperSubstantial claim - Interpretationcitation
The more oxidized cytosolic redox state in autism could favor anaerobic glycolysis over oxidative phosphorylation as a source of ATP.
“This more oxidized cytosolic redox state in autism could favor anaerobic glycolysis over oxidative phosphorylation as a source of adenosine triphosphate.28”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Krebs HA Pyridine nucleotides and rate control Symp Soc Exp Biol 1973 27 299 318 4148884
Not checked in the free run.
- Interpretationcitation
The higher plasma pyruvate levels, and in some cases lactate levels, in children with autism are consistent with higher alanine and lactic acid levels reported by others.
“The higher levels of plasma pyruvate (and in some cases accompanied by higher levels of lactate) found in children with autism is consistent with the higher levels of alanine (the transamination product of pyruvate) and lactic acid reported by others.5,23”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [5] Filipek PA Juranek J Nguyen MT Relative carnitine deficiency in autism J Autism Dev Disord 2004 34 6 615 623 15679182
Not checked in the free run.
- cites [23] Aldred S Moore KM Fitzgerald M Waring RH Plasma amino acid levels in children with autism and their families J Autism Dev Disord 2003 33 1 93 97 12708584
Not checked in the free run.
- Interpretationreasoning
Cumulative damage and oxidative stress over time may influence the onset or severity of autism and its comorbid symptoms through reduced capacity to generate functional mitochondria.
“Collectively, these results suggest that cumulative damage and oxidative stress over time may (through reduced capacity to generate functional mitochondria) influence the onset or severity of autism and its comorbid symptoms.”
Quote in the paperSubstantial claim - Interpretationcitation
Oxidative modifications of PDHC and ensuing inactivation are consistent with the higher hydrogen peroxide production and low complex V activity in children with autism.
“Oxidative modifications of PDHC, and the ensuing inactivation elicited by oxidative or nitrative stress, seem consistent with the higher rate of hydrogen peroxide production and the low complex V activity found in children with autism, considering the high sensitivity of this complex to nitration and oxidation of key amino acid residues.27”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Haynes V Traaseth NJ Elfering S Nitration of specific tyrosines in FoF1 ATP synthase and activity loss in aging Am J Physiol Endocrinol Metab 2010 298 5 E978 E987 20159857 PMC2867368
Not checked in the free run.
- Interpretationcitation
The reported population prevalence of mitochondrial disorders in children could be severely underestimated because of diverse clinical presentation.
“Alternatively, the reported population prevalence of mitochondrial disorders in children could be severely underestimated because the diverse clinical presentation32 constitutes a challenge for clinicians to diagnose.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Scaglia F Towbin JA Craigen WJ Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease Pediatrics 2004 114 4 925 931 15466086
Not checked in the free run.
- Study design and conductcitation
Diagnoses were confirmed through clinical examinations using the ADI-R and ADOS.
“Diagnoses were confirmed through clinical examinations using the Autism Diagnostic Inventory-Revised (ADI-R)9 and the Autism Diagnostic Observation Schedule (ADOS).10”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Lord C Rutter M Le Couteur A Autism Diagnostic Interview-Revised J Autism Dev Disord 1994 24 5 659 685 7814313
Not checked in the free run.
- cites [10] Lord C Risi S Lambrecht L The Autism Diagnostic Observation Schedule-Generic J Autism Dev Disord 2000 30 3 205 223 11055457
Not checked in the free run.
- Interpretationcitation
The percentage of definite mitochondrial respiratory chain disorder in this autism sample (10%) is similar to the 7.2% reported by others despite different experimental designs.
“This percentage is similar to that reported by others (7.2%) despite using a different experimental design (skeletal muscle biopsies, high lactate-to-pyruvate ratio screening, participants aged 7-9 years with ASD4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Oliveira G Diogo L Grazina M Mitochondrial dysfunction in autism spectrum disorders: a population-based study Dev Med Child Neurol 2005 47 3 185 189 15739723
Not checked in the free run.
- Interpretationreasoning
The observed incidence of definite mitochondrial respiratory chain disorder in children with autism could be 550 to 770 times higher than that of the general population.
“Thus, the observed incidence in children with autism could be 550 to 770 times higher than that of the general population.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Skladal D Halliday J Thorburn DR Minimum birth prevalence of mitochondrial respiratory chain disorders in children Brain 2003 126 pt 8 1905 1912 12805096
Not checked in the free run.
- The authors state this as an assumption: Mitochondrial respiratory chain disorders and autism spectrum disorder are unrelated or independent conditions.
- Interpretationreasoning
PDHC deficiency could contribute to brain dysfunction in autism.
“Hence, PDHC deficiency could contribute to brain dysfunction in autism.”
Quote in the paperSubstantial claim- Rests on an assumption: Defects in PDHC lead to inadequate removal of pyruvate and lactate, resulting in insufficient energy production.
- Interpretationcitation
A defect in the PDHA1 gene could play a role in the 4:1 male-to-female ratio in autism.
“The major cause of PDHC deficiency is mutations in the X-linked gene coding for the PDHA1 subunit25; thus, a defect in this gene could play a role in the 4:1 ratio of males to females with autism.26”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [25] Lissens W De Meirleir L Seneca S Mutations in the X-linked pyruvate dehydrogenase (E1) alpha subunit gene (PDHA1) in patients with a pyruvate dehydrogenase complex deficiency Hum Mutat 2000 15 3 209 219 10679936
Not checked in the free run.
- cites [26] Autism and Developmental Disabilities Monitoring Network Surveillance Year 2000 Principal Investigators; Centers for Disease Control and Prevention Prevalence of autism spectrum disorders MMWR Surveill Summ 2007 56 1 1 11 17287714
Not checked in the free run.
- Premisecitation
The lactate-to-pyruvate ratio reflects the redox state of the cytosolic compartment.
“The lactate-to-pyruvate ratio reflects the redox state of the cytosolic compartment,28 such that a lactate-to-pyruvate ratio of 12 (as in controls) indicates a ratio of oxidized NADH to reduced NADH of 750:1 and a lactate-to-pyruvate ratio of 6 (as in autism) indicates a ratio of oxidized NADH to reduced NADH of 1500:1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Krebs HA Pyridine nucleotides and rate control Symp Soc Exp Biol 1973 27 299 318 4148884
Not checked in the free run.
- May combine two claims. 21
- Classified as probably not a substantial claim. 17
May combine two claims.
Findingown dataEight of 10 children with autism had higher pyruvate levels, but only 2 had higher lactate levels compared with controls.
“Eight of 10 cases had higher pyruvate levels but only 2 cases had higher lactate levels compared with controls.”
- Also stated in: § RESULTS · plain
“Two of 10 children with autism had high lactate levels and 8 had high pyruvate levels.”
Quote in the paperSubstantial claim- Also stated in: § RESULTS · plain
May combine two claims.
Findingown dataSuccinate oxidase, cytochrome c oxidase, and adenosine triphosphatase activities in children with autism were not different from control values.
“However, the values for succinate oxidase, cytochrome c oxidase, and adenosine triphosphatase activities in children with autism were not different from the control values (Table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataLow NADH oxidase activity was the most common deficiency (8 of 10), followed by succinate oxidase (6 of 10), ATPase or complex V (4 of 10), and complex IV or cytochrome c oxidase (3 of 10).
“Using the control values to define a reference range (set at 99% CI) for the individual data, low NADH oxidase activity was the most common deficiency (8 of 10), followed by succinate oxidase (6 of 10), adenosine triphosphatase or complex V (4 of 10), and complex IV or cytochrome c oxidase (3 of 10) (Table 2).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMitochondrial DNA overreplication was found in 5 of 10 children with autism, with a mean mtDNA-to-nuclear-DNA ratio of 239 versus 179 in controls (P=10−4).
“Mitochondrial DNA overreplication was found in 5 cases (mean ratio of mtDNA to nuclear DNA: 239 [95% CI, 217-239] vs 179 [95% CI, 165-193] in controls; P=10−4).”
- Also stated in: § RESULTS · plain
“However, 5 of 10 children with autism presented mtDNA overreplication leading to a higher mean value of 239 (95% CI, 217-239) compared with 179 (95% CI, 165-193) for control children (P=10−4).”
Quote in the paperSubstantial claim- Also stated in: § RESULTS · plain
May combine two claims.
Findingown dataDeletions at the cytochrome b segment were observed in 2 of 10 children with autism, with a mean cytochrome b-to-ND1 ratio of 0.80 versus 0.99 in controls (P=.01).
“Two of 10 children with autism presented deletions at the segment of cytochrome b (ratio of cytochrome b to ND1: 0.80 [95% CI, 0.68-0.92] vs 0.99 [95% CI, 0.93-1.05] for controls; P=.01), whereas there were no deletions at the segment encoded by ND4 (Table 3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNo statistically significant differences were found in mean glycemia or lactate levels between children with autism and controls.
“No statistically significant differences were found in the mean values for glycemia or lactate level between cases and controls.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationThe increased reactive oxygen species production observed is consistent with the higher ratio of oxidized NADH to reduced glutathione in lymphoblastoid cells and mitochondria from children with ASD, supporting higher oxidative stress in these cells.
“The increased reactive oxygen species production observed in this exploratory study is consistent with the higher ratio of oxidized NADH to reduced glutathione in lymphoblastoid cells and mitochondria from children with ASD,33 supporting the concept that these cells from children with autism present higher oxidative stress.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [33] James SJ Rose S Melnyk S Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism FASEB J 2009 23 8 2374 2383 19307255 PMC2717775
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataCases and controls had similar age, sex, and ethnicity, although controls were more likely to be nonwhite.
“Cases and controls had similar age, sex, and ethnicity, although controls were more likely to be nonwhite.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataTen group comparisons were made; 6 were significant at α=.05 and 2 at α=.005 using Bonferroni correction.
“Ten group comparisons were made in this study; of these comparisons, 6 were significant at the α level of .05 and 2 were significant at the α level of .005 (ie, using the conservative Bonferroni correction).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductown dataThe possibility of type I errors should be considered.
“Second, the possibility of type I errors should be considered.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataIn this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children.
“In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe differences between cases and controls could represent confounding due to possible associations between mitochondrial dysfunction and race, which differed by case-control status.
“Fourth, the differences observed between our cases and controls could represent confounding effects due to possible associations between mitochondrial dysfunction and race, which also differed by case-control status.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIncreased reactive oxygen species production induced by dysfunctional mitochondria could elicit chronic oxidative stress that enhances mtDNA replication and possibly mtDNA repair.
“Increased reactive oxygen species production induced by dysfunctional mitochondria could elicit chronic oxidative stress that enhances mtDNA replication, and possibly mtDNA repair.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationcitationAlthough skeletal muscle can tolerate this shift in metabolism, consequences for brain function could be devastating due to its heavy reliance on mitochondrial oxidative phosphorylation.
“Although skeletal muscle can tolerate this shift in metabolism, consequences for brain function could be devastating due to its heavy reliance on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes.7,29”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [7] Schapira AH Human complex I defects in neurodegenerative diseases Biochim Biophys Acta 1998 1364 2 261 270 9593927
Not checked in the free run.
- cites [29] Erecinska M Nelson D Silver IA Metabolic and energetic properties of isolated nerve ending particles (synaptosomes) Bioenergetics 1996 1277 1-2 13 34 8950370
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenExperiments were run in triplicate and repeated at least 2 times in independent experiments unless noted otherwise.
“Experiments were run in triplicate and repeated at least 2 times in independent experiments unless noted otherwise.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductreasoningCaution should be exercised in generalizing the findings to a larger population.
“Nevertheless, caution should be exercised with regard to the generalization of findings in a larger population.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe higher mtDNA copy number could represent a compensatory mechanism to increase wild-type mtDNA templates and maintain normal mitochondrial transcript levels.
“The higher mtDNA copy number could represent a compensatory mechanism to increase the number of wild-type mtDNA templates and maintain normal levels of mitochondrial transcripts.35”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Williams RS Mitochondrial gene expression in mammalian striated muscle J Biol Chem 1986 261 26 12390 12394 3745193
Not checked in the free run.
May combine two claims.
Study design and conductown dataDemographic and clinical data for the larger CHARGE study population were comparable with the subset, except the 10 autism cases were somewhat higher functioning.
“Demographic and clinical data for the larger CHARGE study population were comparable with those for the subset used in this study, except that the 10 cases with autism were somewhat higher functioning than the cases with autism from the original CHARGE study sample; therefore, the case-control differences in cognitive and adaptive scores were somewhat attenuated (TABLE 1).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataControls were screened for ASD with the Social Communication Questionnaire, and those above cutoff were fully assessed with the ADI-R and ADOS.
“The Social Communication Questionnaire was used to screen for ASD among those recruited as general population controls. Children who scored above the screening cutoff were fully assessed using the ADI-R and the ADOS.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductreasoningThe investigators attempted to achieve comparable age, sex, and race/ethnicity across groups to minimize confounding.
“We also attempted to achieve comparable age, sex, and race/ethnicity across groups to minimize confounding socio-demographic factors that may be surrogates for genetic, epigenetic, or cultural background.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA lactate-to-pyruvate ratio of 12 corresponds to an oxidized NADH to reduced NADH ratio of 750:1, and a ratio of 6 corresponds to 1500:1.
“The lactate-to-pyruvate ratio reflects the redox state of the cytosolic compartment,28 such that a lactate-to-pyruvate ratio of 12 (as in controls) indicates a ratio of oxidized NADH to reduced NADH of 750:1 and a lactate-to-pyruvate ratio of 6 (as in autism) indicates a ratio of oxidized NADH to reduced NADH of 1500:1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Krebs HA Pyridine nucleotides and rate control Symp Soc Exp Biol 1973 27 299 318 4148884
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenChildren from the general population scoring at 71 or above on both Mullen and Vineland scales and without ASD qualified as typically developing controls.
“children from the general population scoring at 71 or above on both of these scales who did not have an ASD qualified as typically developing controls.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataNone of the children had been previously diagnosed with a genetic syndrome or had indications of genetic syndromes.
“Fifth, none of the children in this study had been previously diagnosed with a genetic syndrome or had any indications of genetic syndromes as determined by developmental pediatricians at the Medical Investigations of Neurodevelopmental Disorders Institute.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
InterpretationcitationAlternatively, the mtDNA abnormalities could result from defective replication and/or repair of mtDNA of primary genetic or secondary oxidative-damage origins.
“Alternatively, these mtDNA abnormalities could result from defective replication and/or repair of mtDNA of primary (genetic36) or secondary (oxidative damage to single base pairs inflicted by free radicals37) origins.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] Zeviani M Spinazzola A Carelli V Nuclear genes in mitochondrial disorders Curr Opin Genet Dev 2003 13 3 262 270 12787788
Not checked in the free run.
- cites [37] Giulivi C Boveris A Cadenas E Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA Arch Biochem Biophys 1995 316 2 909 916 7864650
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe study protocol followed the Declaration of Helsinki and was approved by the institutional review board; written informed consent was obtained from a parent.
“The study protocol follows the ethical guidelines of the Declaration of Helsinki15 and was approved by the institutional review board of the University of California, Davis, School of Medicine. All participants enrolled in the study had written informed consent provided by a parent.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [15] World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects 8 11 2010 http://www.hpci.ch/files/documents/guidelines.hh_gl_helsinki.pdf. Accessibility verified
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenInferences about a cause-and-effect association between mitochondrial dysfunction and typical autism cannot be made in a cross-sectional study.
“Sixth, inferences about a cause and effect association between mitochondrial dysfunction and typical autism cannot be made in a cross-sectional study.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenThe cases in this substudy were somewhat higher functioning than those from the original study, lessening the difference with controls.
“Third, the cases in this substudy were somewhat higher functioning than those from the original study, lessening the difference with controls.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationSome complex activities above the control interval in 2 cases might represent an attempt to compensate for low PDHC activities or other mitochondrial dysfunction.
“Some complex activities were found above the control interval in 2 cases (Table 2 and eTable 2 at http://www.jama.com). This might represent an attempt to compensate for the low PDHC activities (or other mitochondrial dysfunction), as has been observed in other mitochondrial disorders.30”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Barrientos A In vivo and in organello assessment of OXPHOS activities Methods 2002 26 4 307 316 12054921
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe number of individuals assessed for mitochondrial activities was relatively small, although the sample size based on statistical power was adequate.
“First, the number of individuals in which mitochondrial activities were assessed was relatively small, although the sample size (based on statistical power for discovery of effects) was adequate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationDefects in genes other than those tested could have been present in these samples.
“Nevertheless, defects (other than deletions) in genes (other than those tested) could have been present in these samples as recently reported in another study of ASD.38”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Pinto D Pagnamenta AT Klei L Functional impact of global rare copy number variation in autism spectrum disorders Nature 2010 466 7304 368 372 20531469 PMC3021798
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenA final CHARGE study diagnosis of autism required meeting ADI-R criteria on communication, social, and repetitive behavior domains and scoring at or above the ADOS cutoff for autistic disorder.
“A final CHARGE study diagnosis of autism was defined as meeting criteria on the communication, social, and repetitive behavior domains of the ADI-R and scoring at or above the cutoff for autistic disorder on the ADOS (module 1, 2, or 3).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDifferences in mtDNA parameters between control children and children with autism could stem from either higher oxidative stress or inadequate removal of harmful species.
“Differences in mtDNA parameters between control children and those with autism could stem from either higher oxidative stress33 or inadequate removal of these harmful species.34”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [33] James SJ Rose S Melnyk S Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism FASEB J 2009 23 8 2374 2383 19307255 PMC2717775
Not checked in the free run.
- cites [34] Ming X Johnson WG Stenroos ES Genetic variant of glutathione peroxidase 1 in autism Brain Dev 2010 32 2 105 109 19195803
Not checked in the free run.
The authors state this as an assumption.
Many mitochondrial defects may not be confined to muscle or brain, so detecting them in readily available lymphocytes and platelets is valuable.
“the detection of mitochondrial defects in readily available cells from body fluids (lymphocytes and platelets7) would be valuable under the assumption that many such defects may not be confined to muscle or the brain, tissues in which mitochondrial diseases are most strongly evident.”
The paper relies on this without support.
Defects in PDHC lead to inadequate removal of pyruvate and lactate, resulting in insufficient energy production.
“Defects in PDHC lead to inadequate removal of pyruvate and lactate, resulting in insufficient energy production.”
The authors state this as an assumption.
Mitochondrial respiratory chain disorders and autism spectrum disorder are unrelated or independent conditions.
“assuming that these 2 clinical conditions are unrelated or independent”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Several lines of evidence indicate oxidative stress and mitochondrial dysfunction are prevalent in individuals with ASD.
“There are presently several lines of evidence indicating oxidative stress and mitochondrial dysfunction are prevalent in individuals with ASD [3,10,11,12,13,14,15,16].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
mtDNA mean does not match its confidence interval
MinorThe reported mean of 239 equals the upper confidence limit, while the midpoint of the stated 217-239 interval is 228. A two-sided t-test confidence interval for a mean should be centered on that mean.
Reported 239 · recomputed 228
“239 (95% CI, 217-239)”
The cited study has two different age ranges
MinorThe paper describes the study cited as reference 4 as involving children aged 10 to 14 years, but later describes its participants as aged 7 to 9 years.
“A school-based study of 69 children aged 10 to 14 years with confirmed autism or ASD found mitochondrial respiratory chain dysfunction in 7.2%.4”
“participants aged 7-9 years with ASD4”
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065 · see citing works
Lord, C., Risi, S., Lambrecht, L., Cook, E. H., Leventhal, B. L., DiLavore, P. C., Pickles, A., & Rutter, M. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005592401947 · Cited by 7,520 · see citing works
Mullen Scales of Early Learning
Bradley‐Johnson, S. (1997) · Psychology in the Schools · doi:10.1002/(sici)1520-6807(199710)34:4 · Cited by 2,329 · see citing works
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · see citing works
Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells
Robin, E. D., & Wong, R. J. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041360316 · Cited by 656 · see citing works
A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues.
Cortopassi, G. A., Shibata, D. K., Soong, N.-W., & Arnheim, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7370 · Cited by 639 · see citing works
Diagnostic criteria for respiratory chain disorders in adults and children
Bernier, F. P., Boneh, A., Dennett, X., Chow, C. W., Cleary, M., & Thorburn, D. R. (2002) · Neurology · doi:10.1212/01.wnl.0000033795.17156.00 · Cited by 574 · see citing works
Minimum birth prevalence of mitochondrial respiratory chain disorders in children
Skladal, D. (2003) · Brain · doi:10.1093/brain/awg170 · Cited by 487 · see citing works
Clinical Spectrum, Morbidity, and Mortality in 113 Pediatric Patients With Mitochondrial Disease
Scaglia, F., Towbin, J. A., Craigen, W. J., Belmont, J. W., Smith, E. O., Neish, S. R., Ware, S. M., Hunter, J. V., Fernbach, S. D., Vladutiu, G. D., et al. (2004) · PEDIATRICS · doi:10.1542/peds.2004-0718 · Cited by 463 · see citing works
Hertz‐Picciotto, I., Croen, L., Hansen, R. L., Jones, C. R., de Water, J. V., & Pessah, I. N. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.8483 · Cited by 420 · see citing works
Self-citationThe prevalence of autism spectrum disorders
Charman, T. (2002) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-002-0297-8 · Cited by 368 · see citing works
Energy Thresholds in Brain Mitochondria
Davey, G. P., Peuchen, S., & Clark, J. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12753 · Cited by 361 · see citing works
Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR
He, L. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf067 · Cited by 320 · see citing works
Oxidative Stress-related Alteration of the Copy Number of Mitochondrial DNA in Human Leukocytes
Liu, C., Tsai, C.-S., Kuo, C., Chen, H., Lii, C., Ma, Y., & Wei, Y. (2003) · Free Radical Research · doi:10.1080/10715760310001621342 · Cited by 285 · see citing works
Williams, R. S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67252-7 · Cited by 273 · see citing works
Diagnostic Uses of the Vineland Adaptive Behavior Scales
Sparrow, S. S., & Cicchetti, D. V. (1985) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/10.2.215 · Cited by 269 · see citing works
Mitochondrial dysfunction in autism spectrum disorders: a population-based study
Oliveira, G., Diogo, L. M., Grazina, M. M., Garcia, P., Ataíde, A., Marques, C., Miguel, T., Borges, L., Vicente, A., & Oliveira, C. R. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000332 · Cited by 267 · see citing works
In vivo and in organello assessment of OXPHOS activities
Barrientos, A. (2002) · Methods · doi:10.1016/s1046-2023(02)00036-1 · Cited by 266 · see citing works
James, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S. J., Pavliv, O., & Gaylor, D. W. (2009) · The FASEB Journal · doi:10.1096/fj.08-128926 · Cited by 223 · see citing works
Pyruvate dehydrogenase deficiency.
Brown, G. K., Otero, L. J., LeGris, M., et al. (1994) · Journal of Medical Genetics · doi:10.1136/jmg.31.11.875 · Cited by 197 · see citing works
Relative Carnitine Deficiency in Autism
Filipek, P. A., Juranek, J. J., Nguyen, M. T., Cummings, C., & Gargus, J. J. (2004) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-004-5283-1 · Cited by 197 · see citing works
Giulivi, C., Boveris, A., & Cadenas, E. (1995) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1995.1122 · Cited by 189 · see citing works
Self-citationPlasma amino acid levels in children with autism and their families
Aldred, S., Moore, K. M., Fitzgerald, M., & Waring, R. H. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1022238706604 · Cited by 188 · see citing works
Human complex I defects in neurodegenerative diseases
Schapira, A. H. V. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00032-2 · Cited by 166 · see citing works
Mitochondrial dysfunction in autistic patients with 15q inverted duplication
Filipek, P. A., Juranek, J. J., Smith, M., Mays, L. Z., Ramos, E. R., Bocian, M. E., Masser‐Frye, D., Laulhere, T. M., Modahl, C., Spence, M. A., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10596 · Cited by 149 · see citing works
Filiano, J. J., Goldenthal, M. J., Rhodes, C. H., & Marı́n-Garcı́a, J. (2002) · Journal of Child Neurology · doi:10.1177/088307380201700607 · Cited by 143 · see citing works
Betts, J., Jaros, E., Perry, R. H., Schaefer, A. M., Taylor, R. W., Abdel‐All, Z., Lightowlers, R. N., & Turnbull, D. M. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00731.x · Cited by 142 · see citing works
Neurometabolic disorders and dysfunction in autism spectrum disorders
Zecavati, N., & Spence, S. J. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0021-x · Cited by 110 · see citing works
Nuclear genes in mitochondrial disorders
Zeviani, M., Spinazzola, A., & Carelli, V. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00052-2 · Cited by 88 · see citing works
Genetic variant of glutathione peroxidase 1 in autism
Ming, X., Johnson, W. G., Stenroos, E. S., Mars, A. E., Lambert, G. H., & Buyske, S. G. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.12.017 · Cited by 80 · see citing works
Fischer, J., Ruitenbeek, W., Stadhouders, A. M., Trijbels, J. M. F., Sengers, R. C. A., Janssen, A. J. M., & Veerkamp, J. H. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90022-1 · Cited by 72 · see citing works
Pyruvate dehydrogenase deficiency: Clinical and biochemical diagnosis
Meırleır, L. D., Lissens, W., Denis, R., et al. (1993) · Pediatric Neurology · doi:10.1016/0887-8994(93)90088-t · Cited by 69 · see citing works
Hao, H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.6.1117 · Cited by 65 · see citing works
Nitration of specific tyrosines in FoF1ATP synthase and activity loss in aging
Haynes, V. L., Traaseth, N. J., Elfering, S. L., Fujisawa, Y., & Giulivi, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00739.2009 · Cited by 58 · see citing works
Self-citationCarbohydrate metabolism in leukocytes
West, J., Morton, D., Esmann, V., et al. (1968) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(68)90306-8 · Cited by 54 · see citing works
Shay, J. W., Pierce, D. J., & Werbin, H. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77184-6 · Cited by 54 · see citing works
Metabolic and energetic properties of isolated nerve ending particles (synaptosomes)
Erecińska, M., NELSON, D. S., & Silver, I. A. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(96)00103-x · Cited by 51 · see citing works
Effects of chronic lead exposure on 1 H MRS of hippocampus and frontal lobes in children
Meng, X.-M., Zhu, D., Ruan, D.-Y., She, J. Q., & Luo, L. (2005) · Neurology · doi:10.1212/01.wnl.0000160391.58004.d4 · Cited by 37 · see citing works
Pyridine nucleotides and rate control.
Ha, K. (1973) · PubMed · Cited by 34 · see citing works
STJERNHOLM, R. L. (1967) · Journal of Bacteriology · doi:10.1128/jb.93.5.1657-1661.1967 · Cited by 32 · see citing works
Role of Mitochondrial Oxygen and Nitrogen Reactive Species in Signaling
Giulivi, C., & Oursler, M. J. (2003) · Springer eBooks · doi:10.1007/0-306-48412-9_17 · Cited by 9 · see citing works
Self-citationLissens, W., Meırleır, L. D., Seneca, S., Liebaers, I., Brown, G. K., Brown, R. M., Ito, M., Naito, E., Kuroda, Y., Kerr, D. S., et al. (2000) · Human Mutation · doi:10.1002/(sici)1098-1004(200003)15:3 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,622 · see citing works
Self-citationRose, S., Melnyk, S., Pavliv, O., Bai, S., Nick, T. G., Frye, R. E., & James, S. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.61 · Cited by 480 · see citing works
Sulforaphane treatment of autism spectrum disorder (ASD)
Singh, K., Connors, S. L., Macklin, E. A., Smith, K. D., Fahey, J. W., Talalay, P., & Zimmerman, A. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416940111 · Cited by 449 · see citing works
A mitochondrial bioenergetic etiology of disease
Wallace, D. C. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61398 · Cited by 342 · see citing works
Jašarević, E., Howerton, C. L., Howard, C. D., & Bale, T. L. (2015) · Endocrinology · doi:10.1210/en.2015-1177 · Cited by 329 · see citing works
Preeclampsia, Placental Insufficiency, and Autism Spectrum Disorder or Developmental Delay
Walker, C. K., Krakowiak, P., Baker, A., Hansen, R. L., Ozonoff, S., & Hertz-Picciotto, I. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.2645 · Cited by 292 · see citing works
Self-citationKalkbrenner, A. E., Schmidt, R. J., & Penlesky, A. C. (2014) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2014.06.001 · Cited by 268 · see citing works
Tyrka, A. R., Parade, S. H., Price, L. H., Kao, H.-T., Porton, B., Philip, N. S., Welch, E. S., & Carpenter, L. L. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.025 · Cited by 259 · see citing works
The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245 · see citing works
Mitochondrial abnormalities in temporal lobe of autistic brain
Tang, G., Gutierrez Rios, P., Kuo, S.-H., Akman, H. O., Rosoklija, G., Tanji, K., Dwork, A., Schon, E. A., DiMauro, S., Goldman, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.006 · Cited by 194 · see citing works
Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders
Iovene, M. R., Bombace, F., Maresca, R., Sapone, A., Iardino, P., Picardi, A., Marotta, R., Schiraldi, C., Siniscalco, D., Serra, N., et al. (2017) · Mycopathologia · doi:10.1007/s11046-016-0068-6 · Cited by 184 · see citing works
Rose, S., Frye, R. E., Slattery, J., Wynne, R., Tippett, M., Pavliv, O., Melnyk, S., & James, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085436 · Cited by 168 · see citing works
Brain Transcriptional and Epigenetic Associations with Autism
Ginsberg, M. R., Rubin, R. A., Falcone, T., Ting, A. H., & Natowicz, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044736 · Cited by 164 · see citing works
Tipping the balance of autism risk: potential mechanisms linking pesticides and autism
Shelton, J. F., Hertz-Picciotto, I., & Pessah, I. N. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104553 · Cited by 164 · see citing works
Self-citationMitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments
Frye, R. E. (2020) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2020.100829 · Cited by 161 · see citing works
McLennan, Y., Polussa, J., Tassone, F., & Hagerman, R. (2011) · Current Genomics · doi:10.2174/138920211795677886 · Cited by 160 · see citing works
Self-citationKhalifa, A. R. M., Abdel‐Rahman, E. A., Mahmoud, A. M., Ali, M. H., Noureldin, M., Saber, S. H., Mohsen, M., & Ali, S. S. (2017) · Physiological Reports · doi:10.14814/phy2.13125 · Cited by 154 · see citing works
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128 · see citing works
Deficits in bioenergetics and impaired immune response in granulocytes from children with autism
Napoli, E., Wong, S., Hertz-Picciotto, I., & Giulivi, C. (2014) · Pediatrics · doi:10.1542/peds.2013-1545 · Cited by 117 · see citing works
Self-citationFrye, R. E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.134 · Cited by 117 · see citing works
Vitamin D and Autism Spectrum Disorder: A Literature Review
Mazahery, H., Camargo, C., Conlon, C., Beck, K., Kruger, M., & Von Hurst, P. (2016) · Nutrients · doi:10.3390/nu8040236 · Cited by 110 · see citing works
Lindqvist, D., Fernström, J., Grudet, C., Ljunggren, L., Träskman-Bendz, L., Ohlsson, L., & Westrin, Å. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.236 · Cited by 111 · see citing works
Frye, R. E., & Rossignol, D. A. (2016) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s38337 · Cited by 96 · see citing works
The relationship of autism and gluten
Buie, T. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.011 · Cited by 91 · see citing works
FMR1 premutation and full mutation molecular mechanisms related to autism
Hagerman, R., Au, J., & Hagerman, P. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9084-5 · Cited by 85 · see citing works
Jin, L.-W., Horiuchi, M., Wulff, H., Liu, X.-B., Cortopassi, G. A., Erickson, J. D., & Maezawa, I. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2778-14.2015 · Cited by 88 · see citing works
Gandal, M. J., Nesbitt, A. M., McCurdy, R. M., & Alter, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041215 · Cited by 67 · see citing works
Lussu, M., Noto, A., Masili, A., Rinaldi, A. C., Dessì, A., De Angelis, M., De Giacomo, A., Fanos, V., Atzori, L., & Francavilla, R. (2017) · Autism Research · doi:10.1002/aur.1748 · Cited by 67 · see citing works
Park, M. J., Aja, S., Li, Q., Degano, A. L., Penati, J., Zhuo, J., Roe, C. R., & Ronnett, G. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109527 · Cited by 62 · see citing works
Wegiel, J., Flory, M., Kuchna, I., Nowicki, K., Ma, S. Y., Imaki, H., Wegiel, J., Frackowiak, J., Kolecka, B. M., Wierzba-Bobrowicz, T., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0183-5 · Cited by 47 · see citing works
Slattery, J., MacFabe, D., Kahler, S., & Frye, R. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160905123953 · Cited by 20 · see citing works
- Authors
- Giulivi, C., Zhang, Y.-F., Omanska-Klusek, A., Ross-Inta, C., Wong, S., Hertz-Picciotto, I., Tassone, F., & Pessah, I. N.
- Affiliations
- University of California, Davis (US)
- Corresponding author
- Giulivi, Cecilia
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2010-12-01
- Volume
- 304
- Issue
- 21
- Pages
- 2389
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC3915058
- OpenAlex
- W2127492455
- Semantic Scholar
- 7e7ae1277d8a4ad6e75064d38c75bb468c3b5086
- Cited by
- 466
- References
- 44
- Citations by year
- 2026: 16 · 2025: 32 · 2024: 25 · 2023: 38 · 2022: 33 · 2021: 29 · 2020: 24 · 2019: 17 · 2018: 26 · 2017: 32 · 2016: 35 · 2015: 33 · 2014: 27 · 2013: 33 · 2012: 36
- FWCI
- 19.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Autism Speaks (AS2344)
- National Institute of Environmental Health Sciences (R01ES012691, P01-ES-11269, R01ES015359, P01ES011269)
- National Center for Research Resources (P51RR000169)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, mitochondrial dysfunction, oxidative phosphorylation, NADH oxidase, complex I, pyruvate dehydrogenase, hydrogen peroxide production, mitochondrial DNA deletions, mitochondrial DNA copy number, plasma lactate, lymphocytes, children, pyruvate kinase, pyruvate kinase deficiency
- MeSH terms
- Autistic Disorder, Child, Preschool, DNA, Mitochondrial, Female, Humans, Hydrogen Peroxide, Lymphocytes, Male, Multienzyme Complexes, NADH, NADPH Oxidoreductases, Phosphorylation, Case-Control Studies, Gene Deletion, Pyruvic Acid, Lactic Acid, Mitochondrial Diseases, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review